← back to search

Michelle A. Lowes

Rockefeller University · US
Area of research
Dermatology · Immunology
Research interest
Research focused on Hidradenitis suppurativa and Psoriasis, with related work in Dermatology, Comorbidity, Intertriginous. Notable publications include 'North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations', 'Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis', and 'Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project'.
h-index
citations
3,117
works
28
NIH funding
primary concept
email

Recent publications

Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa
JAMA Dermatology 2025cited by 3position: middledoi
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations
Journal of the American Academy of Dermatology 2024cited by 7position: middledoi
Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice
JAMA Dermatology 2023cited by 17position: middledoi
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa
JAMA Dermatology 2022cited by 57position: middledoi
Innate immunity and microbial dysbiosis in hidradenitis suppurativa – vicious cycle of chronic inflammation
Frontiers in Immunology 2022cited by 55position: middledoi
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project
British Journal of Dermatology 2022cited by 27position: middledoi
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
Journal of the American Academy of Dermatology 2021cited by 215position: middledoi
Clinical considerations in the management of hidradenitis suppurativa in women
International Journal of Women’s Dermatology 2021cited by 27position: middledoi
Dermatology COVID-19 Registries
Dermatologic Clinics 2021cited by 20position: middledoi
What causes hidradenitis suppurativa ?—15 years after
Experimental Dermatology 2020cited by 183position: middledoi
Pain management in hidradenitis suppurativa and a proposed treatment algorithm
Journal of the American Academy of Dermatology 2020cited by 77position: middledoi
Special considerations for women with hidradenitis suppurativa
International Journal of Women’s Dermatology 2020cited by 29position: middledoi
Diagnosis and management of hidradenitis suppurativa in women
American Journal of Obstetrics and Gynecology 2020cited by 23position: middledoi
Remote management of hidradenitis suppurativa in a pandemic era of COVID‐19
International Journal of Dermatology 2020cited by 13position: middledoi
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Journal of the American Academy of Dermatology 2019cited by 370position: middledoi
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Journal of the American Academy of Dermatology 2019cited by 367position: middledoi
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
Journal of the American Academy of Dermatology 2019cited by 276position: middledoi
A Comparison of International Management Guidelines for Hidradenitis Suppurativa
Dermatology 2019cited by 116position: middledoi
Distribution of Self-reported Hidradenitis Suppurativa Age at Onset
JAMA Dermatology 2019cited by 70position: lastdoi
Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature
PLoS ONE 2018cited by 88position: lastdoi
A protective Langerhans cell–keratinocyte axis that is dysfunctional in photosensitivity
Science Translational Medicine 2018cited by 84position: middledoi
Quality of life and sexual health in patients with hidradenitis suppurativa
International Journal of Women’s Dermatology 2018cited by 76position: middledoi
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (<scp>SHSA</scp>) 2017
Experimental Dermatology 2018cited by 22position: lastdoi
IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment
Cell 2017cited by 191position: middledoi
Pain, Psychological Comorbidities, Disability, and Impaired Qualify of Life in Hidradenitis Suppurativa
Current Pain and Headache Reports 2017cited by 118position: middledoi
Correction to: Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa
Current Pain and Headache Reports 2017cited by 7position: middledoi
IL-17 and TNF Synergistically Modulate Cytokine Expression while Suppressing Melanogenesis: Potential Relevance to Psoriasis
Journal of Investigative Dermatology 2013cited by 222position: middledoi
Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis
The American Journal of Human Genetics 2012cited by 357position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Haley B. Naik · Northwell Health8 papers (2019–2022)Afsáneh Alavi · Virginia Commonwealth University7 papers (2018–2021)Joslyn S. Kirby · Pennsylvania State University4 papers (2019–2022)Vivian Y. Shi · Providence College4 papers (2019–2020)Jennifer L. Hsiao · University of Southern California4 papers (2019–2021)Christopher J. Sayed · Twitter (United States)3 papers (2019–2021) · 3 papers (2017–2018)Ali Alikhan · University of Vermont3 papers (2019–2021) · 3 papers (2019–2021)Iltefat Hamzavi · Henry Ford Health System3 papers (2019–2021)Alexa B. Kimball · Tufts University3 papers (2019–2021)Raed Alhusayen · University of Saskatchewan3 papers (2019–2021)Mayte Suárez‐Fariñas · Department of Health3 papers (2013–2019)Ladan Afifi · University of California, Los Angeles2 papers (2017–2017)Hadar Lev‐Tov · Rutgers, The State University of New Jersey2 papers (2021–2022)Ram Parvataneni · University of California, Los Angeles2 papers (2020–2020)Dennis P. Orgill · Brigham and Women's Hospital2 papers (2019–2019)Lauren A.V. Orenstein · Emory University2 papers (2020–2021)Karen Crowell · University of Arkansas for Medical Sciences2 papers (2019–2019)Steven R. Cohen · Cornell University2 papers (2017–2017)